Top Markets
#1 SuperVerse SuperVerse +17.39%
#2 Codatta Codatta +12.86%
#3 Audiera Audiera +12.30%
#4 Ski Mask Dog Ski Mask Dog +10.63%
#5 Bless Bless +10.07%
#6 Qkacoin Qkacoin +10.00%
#7 BitMEX BitMEX +9.00%
#8 Amiko Amiko +7.87%
#9 Yooldo Games Yooldo Games +6.87%
#10 Shuffle Shuffle +6.72%
Coin of the day
SuperVerse SuperVerse
Innstillinger
Språk
NORSK
Valuta
USD
Tema
BioNexus Gene Lab Corporation BioNexus Gene Lab Corporation

BioNexus Gene Lab Corporation

BGLC
Rangering i aksjer #18708
BioNexus Gene Lab Corporation, a molecular diagnostics company, focuses on... BioNexus Gene Lab Corporation, a molecular diagnostics company, focuses on developing and commercializing molecular diagnostic tests for the early detection of diseases and personalized health management primarily in Malaysia. Its non-invasive blood tests are used to analyze changes in ribonucleic acid for the detection of Covid-19, Dengue, human immunodeficiency virus, human papillomavirus, and the risk potentiality of cancers diseases. BioNexus Gene Lab Corporation was incorporated in 2017 and is based in Kuala Lumpur, Malaysia with an additional office in Sheridan, Wyoming.
Aksjekurs
$2.49
Markedsverdi
$4.47M
Endring (1 dag)
-4.01%
Endring (1 år)
678.16%
Land
MY
Handel BioNexus Gene Lab Corporation (BGLC)

Kategori

Healthcare
Inntekter for BioNexus Gene Lab Corporation (BGLC)
Inntekter i Sep 2025 TTM: $9.47M
Ifølge de nyeste økonomiske rapportene til BioNexus Gene Lab Corporation er selskapets nåværende inntekter (TTM) $9.47M. I 2023 hadde selskapet inntekter på $9.77M en nedgang sammenlignet med inntektene i 2022, som var $10.93M. Inntektene er det totale beløpet et selskap genererer fra salg av varer eller tjenester. I motsetning til fortjeneste trekkes ingen kostnader fra.
Inntektshistorikk for BioNexus Gene Lab Corporation fra 2016 til 2026
Inntekter ved slutten av hvert år
År Inntekter Endre
2026 (TTM) $9.47M -0.48%
2024 $9.51M -2.66%
2023 $9.77M -10.60%
2022 $10.93M -18.21%
2021 $13.36M 17.31%
2020 $11.39M 8,872.03%
2019 $126.96K -40.21%
2018 $212.33K 97.18%
2017 $107.68K 0.00%
2016 0.00 0.00%
Inntekter for lignende selskaper eller konkurrenter
Selskap Inntekter Forskjell i inntekter Land
Thermo Fisher Scientific Inc. Thermo Fisher Scientific Inc.
Thermo Fisher Scientific Inc.
TMO.US
 $44.56B 470,644.55%
US
Danaher Corporation Danaher Corporation
Danaher Corporation
DHR.US
 $24.57B 259,466.66%
US
IDEXX Laboratories, Inc. IDEXX Laboratories, Inc.
IDEXX Laboratories, Inc.
IDXX.US
 $4.30B 45,369.62%
US
WuXi AppTec Co., Ltd. WuXi AppTec Co., Ltd.
WuXi AppTec Co., Ltd.
2359.HK
 $6.23B 65,758.80%
CN
Agilent Technologies, Inc. Agilent Technologies, Inc.
Agilent Technologies, Inc.
A.US
 $7.07B 74,543.38%
US